We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Kumar - A Phase 1/2 Study of Weekly MLN9708, an Investigational Oral Proteasome Inhibitor, in Combination with Lenalidomide and Dexamethasone in Patients with Previously Untreated Multiple Myeloma (MM)
Shaji Kumar,
Mayo Clinic
Rochester, MN
12.02.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles